Krebs Biochemicals & Industries56.22
-1.09 (-1.90%)

Krebs Biochemicals & Industries Share Price

56.22-1.09 (-1.90%)
-28.77% past 1 Year

Corporate filings & documents

Announcements

The Company has enclosed herewith intimation for closure of trading window for the quarter ended 30.09.2026.
15 hours ago
The Company has enclosed herewith intimation for closure of trading window for the quarter ended 30.09.2026.
15 hours ago
The Company has enclosed herewith copy of Newspaper Advertiesment of the Notice issued to shareholders wrt 34th AGM.
2 weeks ago
The Company has enclosed herewith copy of Newspaper Advertiesment of the Notice issued to shareholders wrt 34th AGM.
2 weeks ago
The Company has enclosed herewith Notice of 34th AGM along with Annual Report FY 2025-26.
2 weeks ago
The Company has enclosed herewith Notice of 34th AGM along with Annual Report FY 2025-26.
2 weeks ago
We are enclosing herewith copy of Annual Report for the financial year ended 31st March 2026.
2 weeks ago
We are enclosing herewith copy of Annual Report for the financial year ended 31st March 2026.
2 weeks ago
The Company has enclosed herewith copy of newspaper advertiesment w.r.t. prior intimation of 34th AGM of the Company.
2 weeks ago
The Company has enclosed herewith copy of newspaper advertiesment w.r.t. prior intimation of 34th AGM of the Company.
2 weeks ago
The Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026
1 month ago
The Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026
1 month ago
Results for the quarter ended 30602026
1 month ago
Results for the quarter ended 30602026
1 month ago
Outcome of BM
1 month ago
Outcome of BM
1 month ago
Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve Intimation of Board Meeting to be held on 6th Agust 2026 interalia to consider and approve unaudited financial results for the quarter ended 30th June 2026.
1 month ago
Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 inter alia to consider and approve Intimation of Board Meeting to be held on 6th Agust 2026 interalia to consider and approve unaudited financial results for the quarter ended 30th June 2026.
1 month ago
The Company has enclosing herewith Certficate recived from RTA under Reg 74 (5) of DP Regulations 2018 for the quarter ended 31.06.2026.
2 months ago
The Company has enclosing herewith Certficate recived from RTA under Reg 74 (5) of DP Regulations 2018 for the quarter ended 31.06.2026.
2 months ago
outcome of Baorad meeting
2 months ago
outcome of Baorad meeting
2 months ago
Outcome of Board Meeting
2 months ago
Outcome of Board Meeting
2 months ago
The Company has enclosed herewith intimation for closure of trading window for the quareter ended 30.06.2026
3 months ago
The Company has enclosed herewith intimation for closure of trading window for the quareter ended 30.06.2026
3 months ago
The Company has enclosed herewith Annual Secretarial Complince Report for the yaer ended 31.03.2026.
3 months ago
The Company has enclosing herewith copy of newspapers advetiement of financial resulst for the quarter and yaer ended 31.03.2026.
4 months ago
Audited Results for fiancial yaer ended 31.03.2026
4 months ago
Outcome of Board Meeting 21.05.2026
4 months ago
Outcome of Board Meeting 21.05.2026
4 months ago
Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Notice is hereby given that meeting of the Board of Directors of the Company will be held on Thursday May 21 2026 inter-alia to consider and adopt the audited financial results for the 4th quarter and financial year ended March 31 2026.
4 months ago
Clarification on price movement
5 months ago
Clarification on price movement
5 months ago
The Exchange has sought clarification from Krebs Biochemicals & Industries Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
5 months ago
The Exchange has sought clarification from Krebs Biochemicals & Industries Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
5 months ago
The Company has enclosing herewith certificate received from RTA under reg 74 (5) of SEBI DP Regulations 2018 for the quarter ended 31.03.2026.
5 months ago
The Company has enclosing herewith certificate received from RTA under reg 74 (5) of SEBI DP Regulations 2018 for the quarter ended 31.03.2026.
5 months ago
The Company has enclosinh herewith intimation for closure of trading window for considaration of audited financial results for the 4th quarter and year ended 31.03.2026.
6 months ago
The Company has enclosing copy of newspaper advertisement of financial results for the quarter ended 31.12.2025
7 months ago
Result for the quarter ended 31.12.2025
7 months ago
Outcome of Board Meeting
7 months ago
Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Board Meeting intimation to consider and adopt the unaudited financial results for the 3rd quarter and nine months ended December 31 2025
8 months ago
The Company has enclosed herewith report on relodgement of shares for the month of December 2025.
8 months ago
The Company has enclosing herewith certificate recived from RTA under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31.12.2025.
8 months ago
The Company has enclosed herewith intimation for closing of trading window for the quarter ended 31.12.2025
9 months ago
The Company enclosing herewith RTA report on relodgement of trasnfer request of physical shares for the month Nov 2025.
9 months ago
The Company has enclosed herewith re-lodgement certificate received from RTA.
10 months ago
The Company has enclosed herewith copy of newspapers advertisement for financial results for the quarter and half year ended 30.09.2025
10 months ago
Result Sept 2025
10 months ago

Concalls & investor presentations

Empty box

No presentations found

Krebs Biochemicals & Industries Ltd Share Price Today

The Krebs Biochemicals & Industries Ltd share price today is ₹58.10 During the trading session, the Krebs Biochemicals & Industries Ltd share price opened at ₹56.45 and recorded an intraday high of ₹58.90 and a low of ₹55.40 Last closing price was ₹57.31 Over the past 52 weeks, the Krebs Biochemicals & Industries Ltd share price has ranged between ₹38.33 and ₹81.80 The current Krebs Biochemicals & Industries Ltd stock price reflects real-time market activity based on executed trades on the exchange.